|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Under the agreement, Baxter (BAX) will gain commercialization rights for all potential indications of MM-398 outside the U.S. and Taiwan, while Merrimack (MACK) will retain commercialization rights in ...
According to Symmetry Medical (SMA), the proposed sale will recognize the value of the OEM Solutions business and enhance the growth potential of Symmetry Surgical.
The illumigene molecular system uses loop-mediated isothermal DNA amplification technology, which is an efficient system to allow Meridian Bioscience (VIVO) to provide customers the illumipro 10 instrument ...